Pharmacokinetics of chromium-enriched yeast in rats following oral administration
- PMID: 36383250
- DOI: 10.1007/s00210-022-02334-z
Pharmacokinetics of chromium-enriched yeast in rats following oral administration
Abstract
Chromium (Cr) is required for carbohydrate, lipid, and protein metabolisms in humans and animals. Cr insufficiency is associated with diabetes and cardiovascular disease. Chromium-enriched yeast (CrY) is a widely used Cr dietary supplement, but its pharmacokinetics remains unavailable. CrY was orally administered to rats at a single dose of 1 mg Cr/kg, and plasma Cr concentration at different time points was measured by inductively coupled plasma mass spectrometry. Pharmacokinetics of CrY in rats was well fitted to a non-compartmental model. Plasma Cr concentration reached the maximum of 8.68 ± 2.87 ng/mL at 0.25 h, and gradually decreased to 4.05 ± 0.47 ng/mL at 24 h. CrY was rapidly absorbed into the blood and was slowly eliminated after the oral administration, which could lead to the accumulation of Cr in vivo.
Keywords: Chromium; Chromium-enriched yeast; Pharmacokinetic parameter; Pharmacokinetics.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Authority EFS (2009) Inability to assess the safety of chromium-enriched yeast added for nutritional purposes as a source of chromium in food supplements and the bioavailability of chromium from this source, based on the supporting dossiers. EFSA J 7(6):1083. https://doi.org/10.2903/j.efsa.2009.1083 - DOI
-
- Cheng HH, Lai MH, Hou WC, Huang CL (2004) Antioxidant effects of chromium supplementation with type 2 diabetes mellitus and euglycemic subjects. J Agric Food Chem 52(5):1385–1389. https://doi.org/10.1021/jf035074j - DOI
-
- Chinese Nutrition Society (2014) Chinese dietary reference intakes 2013. Science Press, China
-
- Collins BJ, Stout MD, Levine KE, Kissling GE, Melnick RL, Fennell TR, Walden R, Abdo K, Pritchard JB, Fernando RA, Burka LT, Hooth MJ (2010) Exposure to hexavalent chromium resulted in significantly higher tissue chromium burden compared with trivalent chromium following similar oral doses to male F344/N rats and female B6C3F1 mice. Toxicol Sci 118(2):368–379. https://doi.org/10.1093/toxsci/kfq263 - DOI
-
- Febel H, Szegedi B, Huszar S (2001) Absorption of inorganic, trivalent and hexavalent chromium following oral and intrajejunal doses in rats. Acta Vet Hung 49(2):203–209. https://doi.org/10.1556/004.49.2001.2.10 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
